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Summary Elevated expression of matrix metalloproteinases (MMPs), a family of secreted proteinases that degrade matrix components of
basement membranes and connective tissues, is strongly correlated with malignant expression in various human epithelial cancers and
epithelial cancer cell lines. We have tested whether elevated levels of MMP expression are also associated with malignant progression in
human cutaneous squamous cell carcinoma. Constitutive levels of expression of steady-state mRNA and of secreted protein encoded by
three MMP genes (matrilysin, gelatinases A and B) were compared in a unique in vitro model of human skin carcinogenesis. This model is
composed of the parental immortalized non-tumorigenic human keratinocyte line (HaCaT), and three activated c-Harvey-ras-oncogene
transfected variants (A-4, 1-7 and 11-4). Although clone A-4 is non-tumorigenic, clones 1-7 and 11-4 exhibit benign and malignant tumorigenic
phenotypes, respectively, after subcutaneous injection into athymic nude mice. Northern blot, Western blot, and zymogram analyses revealed
three MMP-specific patterns of expression. Constitutive matrilysin mRNA expression was markedly increased in the 1-7 cells compared with
HaCaT, A-4 or 11-4 cells. Secreted promatrilysin was distinctly increased in the tumorigenic 1-7 and 11-4 cells compared with the non-
tumorigenic HaCaT and A-4 cells. Gelatinase A mRNA and secreted gelatinase A protein levels were increased in each transfectant
compared with HaCaT. Both active and inactive forms of gelatinase A were detected. Gelatinase B transcripts were not detected, but an
EDTA-inhibitable gelatinase activity comigrating with gelatinase B was moderately enhanced in both tumorigenic variants compared with the
non-tumorigenic cells. Because promatrilysin and 92-kDa gelatinase secretion were increased in both benign and malignant tumorigenic
cells, and not related to invasiveness in this model, it is concluded that enhanced constitutive expression of these two MMPs is associated
with acquisition of the tumorigenic phenotype, before acquisition of the malignant phenotype.
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The predominant cause ofcancer morbidity and mortality is metas-
tasis ofmalignant cells from the primary tumour to secondary sites.
Therefore, a critical goal in cancertreatment is prevention ofmetas-
tasis, a process that is considered to involve repeated proteinase-
mediated degradation and cancer cell invasion of basement
membranes and underlying connective tissues. Members of the
matrix metalloproteinase (MMP) family of zinc-containing endo-
peptidases may play apivotal role inin vivo invasion and metastasis
because they can degrade matrix components of the basement
membrane. At least 15 different MMPs from human sources have
been characterized (Pendas et al, 1997). MMPs are secreted as
proenzymes, and are subsequently activated. Furthermore, modula-
tion ofMMPactivity by endogenous tissue inhibitors ofmetallopro-
teinases (TIMPs) has been shown to dramatically alter invasive and
metastatic phenotypes of cancer cells (Ray and Stetler-Stevenson,
1994; Birkedal-Hansen et al, 1993). Elucidation ofthe mechanisms
by which multiple MMP activities are generated and coordinated in
vivo has great significance for understanding pathological mecha-
nisms ofinvasion and metastasis ofcancercells.
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Elevated expression levels ofgelatinases A and B (EC 3.4.24.24
and 3.4.24.35), and matrilysin (EC 3.4.24.23) have been strongly
correlated with the invasive or malignant phenotype in human
squamous cell carcinoma (SCC), in human prostate, breast, colon,
gastric and colorectal cancer, and in cultured human cancer cells in
vitro (Stetler-Stevenson, 1990; McDonnell et al, 1991; Mareel et al,
1991; Pajouh et al, 1991; Pyke et al, 1992; Kusukawa et al, 1993;
Powell et al, 1993; Tryggvason et al, 1993). Differential expression
levels ofspecific MMPs in primary human keratinocytes (Petersen
et al, 1989; Sarret et al, 1992), SCCs (Muller et al, 1991; Juarez et
al, 1993) and cultured SCC cell lines (Mulleretal, 1991; Pyke et al,
1992; Juarez et al, 1993; Kusukawa et al, 1993; Shima et al, 1993)
have been described. However, MMP levels were not correlated
with in vivo tumorigenicity.
Transfection of a spontaneously immortalized human keratino-
cyte cell line (HaCaT) (Boukamp et al, 1988) with the activated
c-rasHa oncogene that is most frequently found in human cancers
resulted in a spectrum ofclones expressing the oncogene product.
These clones exhibited two different tumorigenic phenotypes in
vivo after subcutaneous injection into athymic nude mice
(Boukamp et al, 1990): encapsulated cysts (benign tumours) (1-7)
and invasive squamous cell carcinomas (II-4). In addition, c-rasHa-
transfected clones that did not express the activated oncogene
product remained non-tumorigenic (A-4). These tumorigenic
phenotypes were representative of discrete stages of malignant
progression.
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A multistep mechanism for carcinogenesis in human epithelial
cells has also been proposed (Rhim et al, 1990; Thraves et al,
1990; Fusenig et al, 1991; Hurlin et al, 1991; Boukamp et al,
1993). HaCaT and the c-rasHa transfectants thus form a unique
model to study cellular changes associated with malignant
progression in human epithelial cells, and in particular in human
squamous cell carcinoma. In the present study, we investigated
constitutive levels of steady-state expression of matrilysin, gelati-
nase A, and gelatinase B mRNA and secreted protein, to determine
whether alterations in the expression of one or more of these
MMPs is associated with acquisition of the invasive or malignant
phenotype. Expression levels were studied in the parental cell line
(HaCaT) and in three activated c-rasHa oncogene transfectants.
Matrisian and colleagues (1985) have described the inhibition of
expression of stromelysin-1 mRNA in v-rasHa transfected rat
fibroblasts by serum. Relative levels of mRNA expression in the
presence and absence of serum were compared to determine the
effect ofserum supplementation. Part ofthe present study has been
published in abstract form (Meade-Tollin et al, 1992).
MATERIALS AND METHODS
Cell culture
All cell lines were cultured at 37°C in a humidified atmosphere of
5% carbon dioxide and 95% air. All media and supplements were
obtained from Gibco-BRL (Grand Island, NY, USA). The human
keratinocyte cell line HaCaT, and the ras-transfected clones A-4,
1-7 and 11-4 were cultured in Dulbecco's modified Eagle medium
(DMEM). HT1080, a human fibrosarcoma line (ATCC, Bethesda,
MD, USA) was cultured in minimal essential medium (MEM).
All growth media were supplemented with 100 units ml-' peni-
cillin, 100 gg ml-' streptomycin and 10% fetal bovine serum
(FBS). Media for the ras-transfected keratinocytes were supple-
mented with 400 jg ml-' active geneticin sulphate (G418). Cells
were harvested by brief incubation in 1 mm ethylene diamine
tetraacetic acid-phosphate-buffered saline (EDTA-NPBS),
followed by brief trypsinization. To generate conditioned media,
cell monolayers at 80-90% confluency were used. They were
rinsed with PBS. Then, the appropriate medium with or without
serum was added, and the cells were incubated for 48 h.
Conditioned media were collected, centrifuged at 2000 g at room
temperature and stored at -80°C. Gelatinase expression in
HT1080 was stimulated by treating cell monolayers with 10 ng
ml-' 12-O-tetradecanoyl-phorbol-13-acetate (TPA) (CCR, Edina,
MN, USA) for 24 h, after serum starvation for 12 h. This concen-
tration has been previously shown not to be cytotoxic (Brown et
al, 1990). DUC 14 and M 38 cells, a generous gift from Dr W
Powell, were derived by transfection of the human prostate
tumour cell line DU145 with the plasmids pH-B-matrilysin or
pH-B-APr-neo-1 respectively (Powell et al, 1993).
Methanol precipitation of conditioned media
Secreted proteins in conditioned media were precipitated with
4 vol of methanol at -20°C. The precipitates were collected by
centrifugation for 1 h at 10 000 g and 40C, and the pellets were
resuspended in one-tenth of the original volume of medium
without serum. A three- to fivefold concentration of protein was
achieved using this procedure.
RNA isolation
Cells at 80-90% confluency were rinsed with PBS and incubated
for 48 h in serum-free or serum-supplemented medium. Total
RNA was isolated by the acid guanidinium-phenol-chloroform
method (Chomczynski and Sacchi, 1987) and the proportion of
polyadenylated RNA was enhanced by column chromatography
on oligo-dT cellulose (New England Biolabs, Beverly, MA,
USA) (Aviv and Leder, 1972). RNA isolation from M38 and
DUC 14 cell lines was performed as previously described
(Powell et al, 1993).
Northern blot analyses
Radioisotopes were obtained from New England Nuclear
(Wilmington, DE, USA). A 350-bp sequence of the matrilysin
full-length cDNA probe (Muller et al, 1988) was radioactively
labelled with [a-32P]dCTP (3000 Ci mmol-1) by random priming
(US Biochemical, Cleveland, OH, USA). The gelatinase A probe
was a synthetic 80-bp oligonucleotide whose sequence was
complementary to a region of the 3' end of the respective
cDNA sequence (nucleotides 1937-2015) (Midland Scientific,
Midland, TX, USA) (Wilhelm et al, 1989; Basset et al, 1990).
The gelatinase B probe was a synthetic 80-bp oligonucleotide
whose sequence was complementary to a region of the 3' end of
the respective cDNA sequence (92 kDa, nucleotides 2144-2223)
(Midland Scientific) (Collier et al, 1988; Basset et al, 1990).
The 5' termini of the oligonucleotides were labelled with
[y-32P]ATP (600 Ci mmol-1) and T4 polynucleotide kinase
(Biorad, Hercules, CA, USA). Electrophoresis, capillary transfer,
prehybridization, and hybridization of total RNA for matrilysin
and the gelatinases were performed as previously described
(Holladay et al, 1992). After hybridization, the membranes to be
probed for matrilysin were washed three times for 30 min each in
0.1 x sodium chloride-sodium citrate (SSC)-1% SDS at 650C.
Membranes to be probed for gelatinase A were washed twice for
30 min each in 0.1 x SSC-l% SDS at 55°C. Membranes probed
for gelatinase B were washed three times for 30 min each with
1 x SSC-l% SDS at 62°C. Membranes were stripped by washing
with 0.1 x Denhardt's solution (5 mm Tris-HCl, pH 8.0; 0.2 mM
EDTA; 0.05% sodium pyrophosphate) for 1 h at 68°C, or by
boiling in 0.1 x SSC-1.0% SDS. Each membrane was then
rehybridized with a random-primed [32P]cDNA complementary
to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or 7S
RNA to mnonitor for equal loading and transfer of samples. In
duplicate experiments, membranes hybridized with the
matrilysin probe were analysed either with a Molecular
Dynamics phosphorimager (Molecular Dynamics, Sunnyvale,
CA, USA) or exposed to X-OMat film (Kodak, Rochester, NY,
USA) at -800C. In the case of gelatinase A, the membrane was
first analysed with the Molecular Dynamics phosphorimager,
then exposed to X-OMat film at -80°C. Volume integration was
performed on each reactive band with ImageQuant software,
version 3.3 (Molecular Dynamics). Background values were
subtracted, and the resulting values obtained for matrilysin and
gelatinase A were divided by the values obtained for the GAPDH
control for that sample. Expression levels for each MMP mRNA
in serum supplemented HaCaT cells were set at unity, and
relative expression levels of matrilysin and gelatinase A in the
remaining samples were determined.
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Western blot analysis
Conditioned medium samples harvested after 48 h of serum depri-
vation were combined with one-quarter volume of 4 x Laemmli
buffer, resolved on 15% SDS-polyacrylamide gels (Laemmli,
1970) and transblotted to 0.45 gm Immobilon P polyvinylidene
fluoride (PVDF) membranes (Millipore, Bedford, MA, USA) at
200 mA for 2 h at 4°C. The membranes were blocked overnight
with a 2.5% solution ofCarnation dry milk in 10 mM Tris-HCl (pH
8.0), 150 mm sodium chloride, 0.05% Tween 20 (TBST). After
rinsing in TBST, the membranes were incubated with anti-
matrilysin antibody diluted 1:1000 for 3 h at room temperature.
The membranes were washed with 0.1% Triton X-100 in TBST,
0.5 M sodium chloride in TBST and finally in TBST, and incu-
bated with a 1:10 000 dilution of goat anti-rabbit antibody conju-
gated with horseradish peroxidase (Pierce Biochemicals,
Rockford, IL, USA) for 1 h at room temperature. The membranes
were washed with TBST solutions containing 0.1% Triton X-100,
0.5% Triton X-100 and 0.5 M sodium chloride. Reactive bands
were visualized by detection with ECL chemiluminescent reagents
(Amersham, Arlington Heights, IL, USU) and exposure to X-
OMat film. Estimations of size were based on comparison with
molecular weight standards (Amersham). A lysate of insect cells
infected with a baculovirus vector containing a full length
matrilysin cDNA insert was collected by centrifugation at 2000g.
This lysate, a generous gift from Dr David Knox, contained
secreted promatrilysin and was used as a positive control for
matrilysin. Affinity-purified matrilysin rabbit polyclonal antibody,
1.36 mg ml-', was a generous gift from Dr Raymond Nagle ofthe
University of Arizona Pathology Department. This antibody
recognizes the 28-kDa proenzyme form and the 18- and 21-kDa
active forms (Quantin et al, 1989).
Zymogram analysis
Conditioned media were obtained from each cell line after 48 h of
incubation in serum-free media. Total protein in the media was
determined by the Bradford assay (Smith, 1994). Unconcentrated
samples containing equal amounts of total protein were mixed
with one-quarter volume 4x sample buffer (0.25% Coomassie blue
R-250, 0.75 M Tris-HCl, pH 8.0, 25% glycerol, 10% SDS).
Samples were electrophoresed on 15% sodium lauryl sulphate-
polyacrylamide gels containing 1 mg ml' of gelatin (Sigma,
St Louis, MO, USA) (Laemmli, 1970). To activate latent metallo-
proteinases, aliquots of the conditioned media were buffered with
Tris-HCl, pH 7.5, and then treated with 1 mm 4-aminophenylmer-
curic acetate (APMA) (Aldrich, Milwaukee, WI, USA) in 0.1 M
sodium hydroxide for 1 h at 37°C before electrophoresis. Control
aliquots were incubated with an equal volume of 0.1 M sodium
hydroxide. After electrophoresis, gels were washed in 50 mM Tris,
pH 8.0, 2.5% Triton X-100; then in 50 mm Tris, pH 8.0, 150 mM
sodium chloride, 5 mm calcium chloride for 30 min each. Enzyme
digestion ofthe substrate incorporated in the gel occurred during a
16-h incubation at 37°C in digestion buffer (50 mm Tris, pH 8.0;
150 mm sodium chloride; 10 mm calcium chloride). Duplicate gels
were incubated as controls in digestion buffer containing
10 mM EDTA (Sigma) to inhibit MMP activity. Gels were stained
with 0.25% Coomassie G-250 (Biorad, Hercules, CA, USA) in
10% glacial acetic acid-25% methanol, and destained in 25%
methanol-10% glacial acetic acid to visualize cleared zones of
gelatinase activity.
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Figure 1 Northern blot analysis of total RNA from subconfluent cultures of
HaCaT and three ras-transfected keratinocyte cells isolated at 48 h of
incubation in the presence (+) or absence (-) of 10% fetal calf serum.
Constitutive steady-state levels of matrilysin mRNA expression are elevated
in the benign tumorigenic ras clone 1-7. Total RNA isolated from M38 and
DUC 14 cell lines served as negative and positive controls respectively. The
internal RNA loading and transfer control was 7S RNA
Table 1 Relative expression levels of matrilysin and gelatinase A mRNA
Cells Serum Matrilysin Gelatinase A
HaCaT + 1 1
- 0.37 0.8
A-4 + 0.08 1.4
- 0.53 3.3
1-7 + 1.7 2.1
- 0.81 2.6
11-4 + 1.07 1.6
- 0.31 1.2
Northern blot analysis of HaCaT and the c-rasHa transfectants A-4, 1-7 and
11-4 was performed as shown in Figures 1 and 3 and analysed with a
phosphorimager and image analysis software. The values for relative MMP
expression were obtained by dividing the integrated volumes obtained for
matrilysin or gelatinase A in a sample by the integrated volumes obtained for
the respective GAPDH control in that sample. The resulting values were then
normalized by assigning the level in the parental line a value of 1.0 to obtain
relative expression levels for each matrilysin or gelatinase mRNA sample.
RESULTS
Northern blot analysis of matrilysin transcripts
An autoradiogram ofa typical Northern blot analysis ofmatrilysin
mRNA in the four keratinocyte clones is shown in Figure 1. The
DUC 14 line expressed high levels of matrilysin mRNA, as previ-
ously shown (Powell et al, 1993). Under the same conditions,
matrilysin mRNA expression was not observed in M38 cells,
which were used as a negative control (Figure 1). To obtain a more
quantitative analysis of the relative amounts of matrilysin mRNA
expressed than is possible from a visual inspection of an auto-
radiogram, a Northern blot from an independent experiment was
exposed in a phosphorimager cassette and quantitated with the
phosphorimager and image analysis software. The normalized
values are presented in Table 1. In the presence of serum, relative
levels of matrilysin mRNA expression in the benign tumorigenic
variant 1-7 were approximately twice those in 11-4, the invasive
variant, or in HaCaT, the parental line, and were almost absent in
the non-tumorigenic A-4 transfectant. The levels of expression of
matrilysin mRNA in each of the ras-transfected variants except
A-4 were decreased by serum starvation.
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Figure 2 Western blot analysis of conditioned serum-free media from
HaCaT and the ras-transfected keratinocyte cells, treated with APMA or with
0.1 sodium hydroxide to activate metalloproteinases. Constitutive levels of
secreted matrilysin are enhanced in both benign and invasive tumorigenic ras
clones. APMA-treated, (+); sodium hydroxide-treated (-); M, methanol-
precipitated APMA-treated conditioned medium from baculovirus-infected
insect cells, a positive control for matrilysin
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Figure 3 Northern blot analysis of total RNA from subconfluent cultures of
HaCaT cells and the ras-transfected keratinocyte cells, isolated at 48 h of
incubation in the presence (+) or absence (-) of 10% fetal calf serum.
Constitutive steady-state levels of gelatinase A mRNA were found in
tumorigenic and non-tumorigenic keratinocyte transfectants. GAPDH
complementary DNA (cDNA) was used as an internal loading and transfer
control
Western blot analysis of secreted matrilysin
Constitutive promatrilysin secretion was significantly increased in
the tumorigenic variants 1-7 and 11-4 compared with non-
tumorigenic parental HaCaT cells and the ras-transfected variant,
A-4 (Figure 2). Expression patterns ofboth steady-state mRNA and
secreted promatrilysin were similar in that the highest levels were
observed in the 1-7 variant, which forms benign tumours.
Constitutive secretion of active 18- or 21-kDa matrilysin was not
detected in HaCaT, A-4 or 11-4 variants, but a faint band at 21 kDa
was detected in the 1-7 variant. Treatment of both baculovirus and
keratinocyte samples with APMA resulted in the disappearance of
the promatrilysin band. In the samples with high levels of pro-
matrilysin expression, two lower molecular weight bands that co-
migrated with active matrilysin appeared after APMA treatment.
No reactivity corresponding to pro- or activated matrilysin was
observed in controls incubated with secondary antibody only (data
not shown). Similar levels of secreted promatrilysin and lack of
secretion ofactive matrilysin were observed in serum-supplemented
conditioned media (data not shown).
Northern blot analysis of gelatinase A and B transcripts
In Figure 3, an autoradiogram ofatypical Northern blot analysis of
gelatinase A and GAPDH mRNA expressed by the keratinocyte
cells is shown. The relative expression levels were quantitatively
assessed by phosphorimager analysis and the normalized data are
presented in Table 1. In serum-free medium, levels ofA-4 and I-7
transcripts were elevated, whereas those of HaCaT and 11-4 were
decreased. A greater than twofold increase was observed in the
A-4 cells in the absence of serum. Levels of gelatinase A mRNA
transcripts after culture in serum-supplemented media were found
to be moderately elevated in ras transfectants compared with the
parental cells.
Under the same analysis conditions as for gelatinase A, the
gelatinase B mRNA was not detectable in total RNA from the
keratinocytes (data not shown). Gelatinase B RNA was easily
detected as a 2.8-kb transcript in 0.34 gg of HT1080 poly-A
selected RNA, but was still not detectable in ten times as much
(3,g) of poly A-selected RNA from any of the keratinocyte
lines (data not shown).
Zymogram analysis of activities of secreted gelatinases
Zones of substrate digestion of the zymograms were consistent
with the expected positions ofboth latent and activated gelatinase
HT HaCaT A-4 1-7 11-4
+ + + - + APMA
97.4 kDa-
69 kDa-
ilatinase B
nase B
ilatinase A
naseA
Figure 4 Gelatin zymograms of unconcentrated conditioned serum-starved
medium from HaCaT and three ras-transfected keratinocyte cells. Gelatinase
A activity predominates and is increased in the ras-transfected clones.
Unconcentrated conditioned medium from TPA-treated HT1080 (HT) served
as a positive control. Duplicate aliquots of each sample were treated (+) or
not (-) with APMA to support characterization of the activities as MMPs. The
positions of bands produced by molecular weight standards are indicated.
Conditioned medium from TPA-treated HT1080, a positive control for
gelatinases A and B, served as a positive control
A and B, and co-migrated with those of gelatinase A and B
observed in the positive control, HT1080-conditioned medium
(Figure 4). The larger part of total gelatinase activity secreted by
each variant was attributable to gelatinase A. Active and inactive
forms of gelatinase A were expressed in relatively equal propor-
tions in each variant, notwithstanding the different tumour pheno-
types and were similarly elevated in the ras-transfected clones
(A-4, 1-7 and II-4) compared with the parental line (HaCaT).
Levels ofgelatinase activity co-migrating with the HT1080 gelati-
nase B were clearly visible in all cell lines, in spite of the lack
of detectable gelatinase B mRNA. Virtually all constitutively
secreted 92-kDa gelatinase in the untreated samples was present in
the proenzyme form. A reproducible moderate increase in 92-kDa
gelatinase activity was observed in the tumorigenic I-7 and II-4
lines compared with the non-tumorigenic lines HaCaT and A-4.
APMA-treated samples exhibited a decrease in the higher molec-
ular weight latent forms and an increase in the lower molecular
weight active forms characteristic of activation of latent gelati-
nases A and B. The increase in 92-kDa gelatinase activity in the
tumorigenic cells was particularly evident after APMA pretreat-
ment for increased levels of the activated form, and clearly
detectable levels corresponding to the latentform were observed in
the tumorigenic I-7 and 11-4 lines. In the lanes corresponding to the
non-tumorigenic cells HaCaT and A-4, levels of latent activity
werebarely detectable afterAPMA treatment. All gelatinase activ-
ities were eliminated in duplicate gels incubated in digestion
buffer containing 10 mM EDTA, an inhibitor of MMP activity
(data not shown).
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DISCUSSION
The multistep nature of carcinogenesis is well established, but
there are few models for investigation of the sequence of events in
human epithelial cancer. In cultured normal mouse keratinocytes,
introduction of the v-rasHa gene led to expression of a benign
tumour (papilloma) phenotype (Roop et al, 1986). A similar effect
was not observed in normal human keratinocytes after ras onco-
gene introduction (Henrard et al, 1990). The four HaCaT-ras trans-
fectants used in this study, which possess different tumorigenic
phenotypes, provide an excellent tool for the investigation of steps
involved in malignant progression. Expression levels of the acti-
vated c-rasHa oncogene in these ras transfectants did not correlate
with the malignant phenotype in vivo, so additional cellular events
were proposed as requirements for malignancy (Boukamp et al,
1990). Whether expression of specific MMPs is related to specific
steps in carcinogenesis is unknown; therefore, we have investi-
gated constitutive expression of matrilysin and gelatinases A and
B in these transfectants.
These three MMPs are expressed during normal tissue remod-
elling, and their enhanced expression has been frequently corre-
lated with invasive and metastatic potential in vitro and in vivo,
although tissue expression levels in carcinomas can vary (Muller
et al, 1991). Constitutive expression of 92- and 66-kDa gelatin-
ases and interstitial procollagenase has been detected in early
passage cultures of human neonatal foreskin keratinocytes, and
the majority of the type IV collagenase activity was due to
gelatinase B (Petersen et al, 1989; Sarret et al, 1992). In the
immortalized HaCaT parental and variant cells, we observed
that gelatinase A activity predominated, reflecting a difference
between primary and spontaneously immortalized keratinocytes
in culture. Constitutive expression of a 92-kDa gelatinase activity
has been detected in a human keratinocyte cell line immortalized
by adenovirus 12-SV40 virus (RHEK) and transformed with an
activated c-rasHa gene (Chen et al, 1993). Secreted 92-kDa
activity indistinguishable from gelatinase B was detected in two
invasive SCC cell lines from the oral cavity, and in one out of four
human oesophageal SCC cell lines (Shima et al, 1993).
Gelatinase B, but not gelatinase A, was also detected in resected
human SCCs from four patients (Juarez et al, 1993). Cancer cells
at the tumour/stroma border in six out of nine SCCs expressed
gelatinase B (Pyke et al, 1992).
In the present study, we have confirmed and extended our initial
report that the HaCaT cells constitutively express matrilysin
mRNA (Meade-Tollin et al, 1992). Our results demonstrated the
association of enhanced expression levels in vitro of matrilysin
mRNA and secreted promatrilysin with tumorigenicity, but not
with the invasive phenotype. The increased secretion of pro-
matrilysin protein by the invasive cells, without increased steady-
state mRNA expression, may be a result of a gene-specific
post-transcriptional regulation. Transcriptional regulation ofMMP
expression is well established, and post-transcriptional regulation
of collagenase and stromelysin has been reported (Delaney and
Brinckerhoff, 1992; Shapiro et al, 1993).
The gelatinase A expression pattern was independent of the
tumorigenic or invasive properties ofthe cell lines. As A-4 cells do
not express activated c-rasHa, but showed similar levels of gelati-
nase A as the other transfected cell lines, it is concluded that latent
and active gelatinase A expression was independent ofthe level of
ras-oncogene expression.
Finally, gelatinase B expression was distinguished by an
absence of detectable gelatinase B mRNA transcripts, but a
reproducible increased secretion of a characteristic 92-kDa
gelatinase activity by the tumorigenic cell lines that comigrated
with gelatinase B secreted by HT1080 cells. The 92-kDa
gelatinase activity we observed also shifted to a lower molecular
weight after APMA treatment. Treatment of a duplicate gel with
EDTA eliminated the activity. Ifthe 92-kDa gelatinase activity is
gelatinase B, inability to detect its steady-state transcript after
48 h could result from: (a) prior degradation of an unstable tran-
script; (b) expression of stable transcript at a steady-state level
below the sensitivity of the Northern blot analysis; (c) absence of
a polyadenylated tract on the 92-kDa transcript that could bind to
oligo-dT cellulose (Peltz et al, 1991); or (d) selective degradation
of the transcript during the isolation procedure. However,
HT1080 gelatinase B transcripts were detected, indicating
gelatinase B transcripts were not selectively degraded (data not
shown). Multiple regulatory elements in the MMP promoter
indicate MMP-9 expression may be coordinately regulated by
several transcription factors (Gum et al, 1996; Bernhard et al,
1995), which might, if present, enhance gelatinase B mRNA
production in vivo.
Recent in vivo studies have indicated that cancer cells are able
to induce production of proteases by neighbouring stromal cells
(Hewitt et al, 1991; Muller et al, 1991; Polette et al, 1991;
Borchers et al, 1994). The inability to identify a specific MMP
gene or genes common to all cancers supports the probability
that progression may be affected by quantitative changes in
levels of expression of one or more MMPs, differential expres-
sion of TIMP inhibitors, or qualitative changes in the specific
genes expressed. In our in vitro model, it is clear that alterations
in constitutive secretion of these three MMPs are observed.
Expression and constitutive secretion of matrix-degrading
enzymes are, however, not the only aspects by which invasive
and non-invasive HaCaT cells differ from each other. Consti-
tutive expression of collagenase 3 and interstitial collagenase
mRNAs in the parental HaCaT line was recently reported
(Johansson et al, 1997). Constitutively secreted collagenase-3
protein was not detected. Treatment with TNFa or TGFP
enhanced collagenase-3 mRNA and proenzyme levels in HaCaT,
but did not enhance mRNA levels in primary keratinocytes.
Constitutive levels of interstitial collagenase were more moder-
ately elevated by these two factors in both primary keratinocytes
and HaCaT cells. Differences also exist in their responses to
positive and negative acting growth factors (Game et al, 1992),
and their ability to induce mesenchymal activation and angio-
genesis (Boukamp et al, 1990; Rhim et al, 1990; Lee et al, 1993;
Fusening and Boukamp, 1994).
In conclusion, we have shown that alterations ofmatrix metallo-
proteases occur with acquisition of tumorigenicity and before
acquisition of the invasive phenotype in this in vitro model. This
observation supports the conclusion that increased levels ofMMP
expression occur early in progression in human skin carcino-
genesis. We have confirmed and extended our previously reported
observations of differential expression of these three MMPs in
vitro in a human keratinocyte model for progression in squamous
cell carcinoma consisting of variants with a range of tumorigenic
phenotypes. We have demonstrated the usefulness of the HaCaT
cells as a model for study of MMP expression and its relationship
to carcinogenesis, tumorigenesis and metastasis.
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